Journal article
Smoking Status and Survival Among a National Cohort of Lung and Colorectal Cancer Patients
Nicotine & tobacco research, Vol.21(4), pp.497-504
03/30/2019
DOI: 10.1093/ntr/nty012
PMCID: PMC6609879
PMID: 29351659
Abstract
The purpose of this study was to explore the association of smoking status and clinically relevant duration of smoking cessation with long-term survival after lung cancer (LC) or colorectal cancer (CRC) diagnosis. We compared survival of patients with LC and CRC who were never-smokers, long-term, medium-term, and short-term quitters, and current smokers around diagnosis.
We studied 5575 patients in Cancer Care Outcomes Research and Surveillance (CanCORS), a national, prospective observational cohort study, who provided smoking status information approximately 5 months after LC or CRC diagnosis. Smoking status was categorized as: never-smoker, quit >5 years prior to diagnosis, quit between 1-5 years prior to diagnosis, quit less than 1 year before diagnosis, and current smoker. We examined the relationship between smoking status around diagnosis with mortality using Cox regression models.
Among participants with LC, never-smokers had lower mortality risk compared with current smokers (HR 0.71, 95% CI 0.57 to 0.89). Among participants with CRC, never-smokers had a lower mortality risk as compared to current smokers (HR 0.79, 95% CI 0.64 to 0.99).
Among both LC and CRC patients, current smokers at diagnosis have higher mortality than never-smokers. This effect should be further studied in the context of tumor biology. However, smoking cessation around the time of diagnosis did not affect survival in this sample.
The results from our analysis of patients in the CanCORS consortium, a large, geographically diverse cohort, show that both LC and CRC patients who were actively smoking at diagnosis have worse survival as compared to never-smokers. While current smoking is detrimental to survival, cessation upon diagnosis may not mitigate this risk.
Details
- Title: Subtitle
- Smoking Status and Survival Among a National Cohort of Lung and Colorectal Cancer Patients
- Creators
- Sandra J Japuntich - Centers for Behavioral and Preventive Medicine, The Miriam Hospital and Department of Psychiatry and Human Behavior, The Alpert Medical School of Brown University, Providence, RIPallavi Kumar - Abramson Cancer Center, University of Pennsylvania, Philadelphia, PAJane F Pendergast - Department of Biostatistics, Duke University School of Medicine, Durham, NCGrelda Yazmin Juarez Caballero - Center for Public Health Statistics, University of Iowa College of Public Health, Iowa City, IAJennifer L Malin - David Geffen School of Medicine at University of California Los Angeles, California and Veterans Affairs Medical Center, Greater Los Angeles, CARobert B Wallace - Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IAElizabeth A Chrischilles - Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IANancy L Keating - Department of Health Care Policy, Harvard Medical School, and Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MAElyse R Park - Department of Psychiatry, Harvard Medical School, Boston, MA
- Resource Type
- Journal article
- Publication Details
- Nicotine & tobacco research, Vol.21(4), pp.497-504
- DOI
- 10.1093/ntr/nty012
- PMID
- 29351659
- PMCID
- PMC6609879
- NLM abbreviation
- Nicotine Tob Res
- ISSN
- 1469-994X
- eISSN
- 1469-994X
- Publisher
- England
- Grant note
- P30 ES005605 / NIEHS NIH HHS K24 CA197382 / NCI NIH HHS P30 CA086862 / NCI NIH HHS
- Language
- English
- Date published
- 03/30/2019
- Academic Unit
- Pharmacy; Epidemiology; Biostatistics; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9983995057202771
Metrics
23 Record Views